Evvy Series B (2026)
Evvy raised $40 million in a Series B round, announced on 2026-09-15. The round was led by Catalio Capital Management.
- Company
- Evvy
- Round type
- Series B
- Date
- 2026-09-15
- Amount
- $40M
- Industry
- women's health, precision medicine, vaginal microbiome
- Location
- New York, NY
Summary
Evvy raised an oversubscribed $40 million Series B on 2026-09-15, led by Catalio Capital Management. New investors included Rethink Impact, Muse Capital and Alumni Ventures. Existing investors including LabCorp Venture Fund, General Catalyst, Left Lane Capital and BBG Ventures also participated. The Business Wire release also names Amboy Street Ventures, Ingeborg, Foreground Capital and Flywheel Ventures.
Investors
Lead
Participating
- Rethink Impact participant
- Muse Capital participant
- Alumni Ventures participant
- LabCorp Venture Fund participant
- General Catalyst participant
- Left Lane Capital participant
- BBG Ventures participant
Sources
Last verified:
- https://techcrunch.com/2026/09/15/evvy-raises-40m-as-it-seeks-to-further-womens-health-research-with-vaginal-microbiome-data/
Type: reputable publication. Accessed 2026-10-07.
TechCrunch article dated 2026-09-15. Reports the $40 million Series B led by Catalio Capital Management and describes Evvy's at-home vaginal microbiome test and EvvyAI. - https://finance.yahoo.com/healthcare/articles/evvy-raises-40m-series-b-130000745.html
Type: funding announcement. Accessed 2026-10-07.
Business Wire release datelined New York, September 15, 2026, read on Yahoo Finance. Confirms the oversubscribed $40 million Series B led by Catalio and lists new and existing investors.